99.1%
HPLC Verified
COA
Available
ISO
Certified Lab
Hexarelin
Potent GH secretagogue with cardioprotective benefits
5mg vial | 5mg/vial
About Hexarelin
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces robust, dose-dependent GH release through the GHSR-1a receptor. It is among the strongest GH-releasing peptides studied, though it does carry a somewhat higher propensity for desensitization than Ipamorelin.
What distinguishes Hexarelin is its remarkable cardioprotective profile. Research has shown that it directly binds to receptors on cardiac tissue (independent of GH release), protecting cardiomyocytes from ischemic damage. Studies in post-MI patients showed improved cardiac function parameters.
Hexarelin also activates PPAR-gamma in macrophages, reducing atherosclerotic plaque formation. This dual growth-hormone and cardiovascular mechanism makes it unique among GH secretagogues.
Key Benefits
Published Research
Peak GH release 20 min post-administration, 5-7x baseline. Cardioprotective effects shown in ischemia-reperfusion models with 35% reduction in infarct size. Improved left ventricular ejection fraction in post-MI patients (Phase 2, N=30).
View Full Research LibraryRelated Products
CJC-1295 / Ipamorelin Blend
The gold standard growth hormone secretagogue stack
MK-677 (Ibutamoren)
Oral growth hormone secretagogue for sustained GH elevation
IGF-1 LR3
Extended-action insulin-like growth factor for muscle growth